Blog
Switching from Mounjaro to Wegovy: A Complete Guide
If you are currently taking Mounjaro and considering a move to Wegovy, you are not alone. Some people switch because of side effects, some because of medication availability, and some simply because their prescriber recommends a different approach for their long-term goals. Whatever the reason, switching between weight loss injections is a medical decision that should never be made without professional guidance. At REX Pharmacy, we support patients through exactly this kind of transition, and this guide walks through the timeline, safety considerations, and practical steps involved.
Before making any changes to your treatment, speak to a pharmacist who can review your current dose, response, and health history.
Quick Answer
Yes, it is possible to switch from Mounjaro (tirzepatide) to Wegovy (semaglutide), and many patients do so successfully. Because the two medications work slightly differently and are not dosed on a like-for-like basis, the switch needs to be planned carefully by a prescriber rather than done independently. In most cases, patients restart Wegovy at a low starting dose rather than jumping in at a level that matches their previous Mounjaro dose, to reduce the risk of side effects.
- Switching is generally done under direct pharmacist or prescriber supervision
- There is no exact dose-for-dose conversion between the two drugs
- Most people restart Wegovy at its lowest dose (0.25mg) and titrate upward
- Timing of the switch depends on your last Mounjaro injection and how your body responds
Why People Switch From Mounjaro to Wegovy
There are several common, legitimate reasons patients move from one medication to the other. Understanding your own reason for switching can help your prescriber tailor the plan to you.
- Side effects. Some patients find the gastrointestinal side effects of tirzepatide, such as nausea or diarrhoea, harder to tolerate than those associated with semaglutide.
- Supply or availability. Medication shortages have affected both drugs at different points, and switching can help maintain continuity of treatment.
- Cost considerations. Pricing between the two medications can vary, and some patients reassess based on their budget or insurance or private prescription costs.
- Formulation preference. With the recently approved oral semaglutide pill, some patients switch specifically to move away from injections altogether.
- Response to treatment. Occasionally a patient’s weight loss plateaus or their tolerance changes, and a prescriber recommends trying a different mechanism of action.
Whatever the reason, the underlying principle stays the same. This is a clinical decision, not a personal experiment, and it should be made in partnership with a healthcare professional.
Is It Safe to Switch?
Switching between GLP-1 based medications is a recognised practice in clinical settings, but it is not something to do casually or without supervision. Both Mounjaro and Wegovy affect similar digestive and hormonal pathways, and your body needs time to adjust from one to the other.
The main safety considerations are:
- No direct dose equivalence. A 10mg dose of Mounjaro does not correspond to a specific dose of Wegovy. The two drugs are dosed independently, which is why most switches restart at Wegovy’s lowest dose.
- Residual drug activity. Tirzepatide has a long half-life, meaning it can remain active in your system for around a week or more after your last injection. Your prescriber will factor this into the timing of your first Wegovy dose.
- Cumulative side effects. Starting Wegovy too soon after your last Mounjaro dose, or at too high a starting dose, can increase the risk of nausea, vomiting, or other digestive symptoms.
- Underlying health conditions. Anyone with a personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or pancreatitis needs a careful reassessment before starting any GLP-1 medication, including as part of a switch.
For most healthy adults who have been tolerating Mounjaro reasonably well, switching to Wegovy under medical supervision is considered low risk. The transition is far safer, and generally far smoother, than stopping one medication abruptly and restarting a different one without a plan.
Who Is a Good Candidate for Switching?
Not everyone who takes Mounjaro needs, or should, switch to Wegovy. A prescriber will usually consider the following before recommending a change:
- You are experiencing side effects on Mounjaro that are affecting your quality of life or ability to continue treatment
- Your current medication has become difficult to source consistently
- You have a clinical reason to prefer a single-hormone mechanism (GLP-1 only) over a dual mechanism (GLP-1 and GIP)
- You are interested in the oral semaglutide pill and want to move away from injections
- Your weight loss has plateaued and your prescriber believes a different approach may help
Switching may be less suitable, or need extra caution, if you have had a poor response to GLP-1 medications in the past, have a complex medical history, or are pregnant, breastfeeding, or planning a pregnancy. In these situations, your pharmacist or prescriber will talk through alternative options with you.
Timeline: What Switching Actually Looks Like
Every switch is individualised, but most follow a broadly similar pattern. Below is a general outline of what to expect, though your prescriber’s exact plan may differ based on your dose history and response.
Step 1: Consultation and Review (Before Switching)
- Your prescriber reviews your current Mounjaro dose, how long you have been taking it, and how you have responded
- Your medical history is reassessed, including any new symptoms or conditions since you started treatment
- You discuss your goals and reasons for switching
Step 2: Timing Your Last Mounjaro Dose
- Because tirzepatide stays active in the body for roughly a week after injection, your prescriber will typically plan your first Wegovy dose to align with when your next Mounjaro dose would have been due
- This usually means a gap of around 7 days between your last Mounjaro injection and your first Wegovy injection, though this varies by individual
Step 3: Starting Wegovy at a Low Dose
- Most patients restart at 0.25mg weekly, the standard Wegovy starting dose, regardless of how high their Mounjaro dose was
- This cautious approach reduces the risk of overlapping side effects and gives your body time to adjust to the new medication
Step 4: Gradual Dose Titration
- Your dose is typically increased every four weeks, following the standard Wegovy escalation schedule, up to a maximum of 2.4mg weekly
- Your prescriber monitors your response and side effects at each stage before increasing further
Step 5: Ongoing Monitoring
- Regular check-ins, whether in person, by phone, or online, help track your weight, side effects, and overall progress
- Bloodwork or other assessments may be repeated periodically, particularly if you have underlying health conditions
In total, a full switch, from your last Mounjaro dose to reaching a stable, effective Wegovy dose, can take several months. This is a normal and expected part of the process, and it mirrors the gradual titration that would happen if you were starting Wegovy for the first time.
Mounjaro to Wegovy: Comparison Table
| Feature | Mounjaro (Tirzepatide) | Wegovy (Semaglutide) |
|---|---|---|
| Mechanism | Dual GLP-1 and GIP receptor agonist | GLP-1 receptor agonist |
| Administration | Once-weekly injection | Once-weekly injection (or daily pill) |
| Approximate half-life | Around 5 days | Around 7 days |
| Starting dose | 2.5mg weekly | 0.25mg weekly |
| Maximum dose | 15mg weekly | 2.4mg weekly |
| Dose equivalence when switching | No direct equivalence, restart at Wegovy’s lowest dose | No direct equivalence, restart at lowest dose |
| Common side effects | Nausea, diarrhoea, reduced appetite, fatigue | Nausea, constipation, diarrhoea, headache |
| Recommended gap after last dose | N/A, this is the medication being switched from | Typically around 7 days after last Mounjaro dose |
| Oral option available | Not currently | Yes, the recently approved Wegovy pill |
These figures are general guidance rather than a fixed protocol, and your prescriber will adjust the plan based on your individual response, dose history, and any side effects you experienced on Mounjaro.
Curious what your results might look like on your new plan? Use our calculator below to get a general sense of what to expect.
Managing Side Effects During the Transition
Because both medications work on overlapping digestive and appetite pathways, some patients notice a change in their symptoms during the switch. This is generally expected and manageable.
- Nausea. Eating smaller, more frequent meals and avoiding rich or fatty foods can help during dose changes.
- Digestive changes. Diarrhoea, constipation, or bloating can occur as your body adjusts. Staying hydrated and maintaining fibre intake often helps.
- Appetite fluctuations. Some patients notice their appetite changes slightly as they move from a dual-hormone medication to a single-hormone one. This usually settles within a few weeks.
- Fatigue. Low energy can occur during any dose adjustment period and typically improves as your body stabilises on the new medication.
If side effects are severe, persistent, or concerning at any point, contact your pharmacist or prescriber promptly rather than waiting for your next scheduled check-in.
What to Expect After Switching
Once you have completed the titration process and reached a stable dose of Wegovy, most patients settle into a similar rhythm to what they experienced on Mounjaro, a once-weekly injection routine with gradually improving appetite control. Weight loss trends after switching vary considerably. Some patients continue to lose weight at a similar pace, others notice a temporary plateau while their body adjusts, and some find their results differ from what they experienced on Mounjaro, given the different mechanism of action.
Your prescriber will continue to monitor your progress and can make further adjustments if needed. It is also worth setting realistic expectations. Because Mounjaro and Wegovy work differently, switching is not guaranteed to replicate identical results, and ongoing lifestyle habits, nutrition, and activity levels remain an important part of the overall picture.
Frequently Asked Questions
Can I switch directly from Mounjaro to Wegovy without a gap?
Generally no. Because tirzepatide remains active in the body for some time after your last dose, most prescribers recommend timing your first Wegovy injection to align with when your next Mounjaro dose would have been due, often around a week later.
Will I lose the progress I made on Mounjaro if I switch?
Switching does not erase your progress, but your body will need to adjust to a new medication. Some patients continue losing weight steadily, while others experience a brief plateau during the transition period.
Do I need to start Wegovy at the lowest dose even if I was on a high dose of Mounjaro?
In most cases, yes. There is no direct dose equivalence between the two medications, so restarting at Wegovy’s lowest dose (0.25mg) is the standard, safer approach, followed by gradual titration.
Is switching covered by the same consultation as starting a new medication?
Typically, yes, though your pharmacist will focus specifically on your treatment history, current dose, and reasons for switching, rather than starting from scratch as they would with a brand-new patient.
Can I switch to the Wegovy pill instead of the injection?
This may be an option depending on your clinical assessment. The oral form works on the same principle as the injection but is taken daily rather than weekly, and your prescriber can advise whether it suits your situation.
What if I experience worse side effects after switching?
Contact your pharmacist or prescriber as soon as possible. Dose adjustments, timing changes, or additional support with managing symptoms can often help, and your treatment plan can be reviewed at any point.
Are there any health conditions that would prevent me from switching?
Yes. A personal or family history of medullary thyroid carcinoma, MEN2 syndrome, or pancreatitis, among other conditions, needs to be reassessed before switching. Your prescriber will screen for these during your consultation.
Making the Switch Safely
Switching from Mounjaro to Wegovy can be a straightforward and safe process when it is planned properly and supervised by a healthcare professional. The key points to remember are that there is no direct dose equivalence between the two medications, timing your first Wegovy dose correctly matters, and a gradual titration schedule helps minimise side effects along the way.
- Never switch medications without professional guidance
- Expect to restart at Wegovy’s lowest dose regardless of your previous Mounjaro dose
- Allow time for your body to adjust, results can take several months to stabilise
- Ongoing monitoring helps catch and manage any side effects early
Ready to talk through your options? Our team at REX Pharmacy can review your current treatment and help you plan a safe, well-supported switch.
You can also get in touch with us if you have any questions before booking.
